nificant proportion of the toxin may be excreted unchanged in urine. 5 The fatal dose of strychnine is variable and patients have survived ingestion of large doses (grams) of strychnine. 6 There is no specific treatment for strychnine poisoning. Management is supportive, along the lines of most poisonings. The stomach is lavaged and activated charcoal administered to prevent further absorption of the toxin. 3 Muscle spasms are controlled by nursing the patient in a quiet environment, with benzodiazepine or barbiturate sedation. Uncontrolled muscle spasms require the addition of muscle relaxants and mechanical ventilation.
Complications of strychnine poisoning include ventilatory failure and hypoxaemia due to the muscle spasms. 4 The increased muscle activity may result in rhabdomyolysis,4 an effect seen to a minor degree in our patient. The intense muscle spasms and rhabdomyolysis may also result in lactic acidosis, hyperthermia 7 and renal failure. 4 Anoxic brain damage and renal failure are the usual causes of death in strychnine poisoning. 1.4 Strychnine poisoning does not commonly present to hospitals in Australia, but the classical clinical course must be recognised early and aggressive therapy instituted to minimise complications.
We report a complication of excision of carotid body tumour under local anaesthesia. The block was complicated by convulsions, probably secondary to intraarterial injection of bupivacaine. The central nervous system (CNS) complications of accidental intra-arterial injection of local anaesthetics are well recognised in stellate ganglion, dental and ophthalmic blocks. They have been termed "focal effects". 1 The importance of injection site in local anaesthetic toxicity is illustrated by this case.
CASE REPORT
The patient, a 78-year-old woman, had a diagnosis of carotid body tumour made by ultrasound and carotid angiography. No significant stenosis of the vessels was present. She had a history of hypertension, diabetes mellitus and thyroidectomy. Drug therapy included captopril, metformin and glibenclamide (omitted on the day of surgery). Preoperative assessment showed no neurological abnormality. Blood pressure was 120/80 and she weighed 63 kg. Resting ECG revealed ventricular extrasystoles. Echocardiography showed moderate aortic incompetence and a mildly dilated left ventricle.
Venous access was established and the patient was monitored with ECG, non-invasive blood pressure and pulse oximetry. Infiltration at the anterior border of sternomastoid was carried out with bupivacainc O.2Yljo 40 ml (100 mg) mixed with three units of ornipressin. Oxygen 6 litres/minute was administered by Hudson mask. No additional sedation was used. Testing with a pin showed adequate anaesthesia and surgery commenced 40 minutes after the block. Twenty minutes after the incision the patient complained of pain. After aspiration with an IS-gauge needle, 2.S ml of 0.2SUJo (6 mg) bupivacaine was injected by the surgeon.
She immediately developed generalised tonic-clonic convulsions. Ventilation with l00UJo oxygen was started. Thiopentone 100 mg and suxamethonium 100 mg were given. She was intubated and ventilated with nitrous oxide and oxygen. Spontaneous respiration returned within five minutes.
The tumour was excised successfully without crossclamping or shunting and the patient awoke an hour after the fit without further incident. Twenty-four hours later she complained only of pain during the initial dissection and was not aware of events following this. At six-week review she was well and the tumour was noted to be a paraganglionoma.
DISCUSSION
The clinical history suggests that the convulsion was due to direct intra-arterial injection of bupivacaine. Even with large doses, bupivacaine infiltration rarely causes convulsions, provided direct intravascular injection does not occur. Moore et al. used up to SO ml of O.SUJo solution (400 mg) for intercostal nerve block in over 2000 patients, with only two convulsions. 2 The convulsive blood level of bupivacaine is around 4 microgram/ml. 3 Neil and Watson 4 gave 3.4±0.9 mg/kg of bupivacaine (O.S%), without adrenaline, for deep cervical plexus block to five patients. Peak concentrations were 4.9 ±0.96 microgram/ml. These patients were under general anaesthesia so toxic effects may have been concealed. After stellate ganglion blockade with only SO mg of bupivacaine, Wulf et al. 5 noted some patients developed mild CNS toxicity, with plasma levels up to 3.2 microgram/ml. The above peak levels, however, occurred less than IS minutes after injection whereas this patient convulsed 60 minutes after injection. Despite this concern about local anaesthetic blood levels in cervical plexus blocks, their safety when used for carotid endarterectomy has been established and no convulsions are reported. 6H Additionally, this block was subcutaneous. The above data refer to deep injection in the neck. Scalp anaesthesia with bupivacaine 0.2SUJo 2 mg/kg without adrenaline has been shown to produce safe peak levels within ten minutes. 9 Such a dose and site of injection are more applicable to this patient, making absorption even less likely to cause the observed convulsion.
Intra-arterial injection removes all the protection of absorption, distribution and binding given by infiltration or even intravenous injection. Thus, when injecting local anaesthetic into an artery supplying the CNS, only 4UJo of the intravenous toxic dose is required to produce toxic levels. Doses as low as 2.S mg of bupivacaine have caused immediate convulsions during stellate ganglion block. 10 Aldrete has also shown that intra-arterial injections in more distal sites, e.g. dental blocks, can produce toxic CNS levels by retrograde flow. 11 We are assuming that our patient received an intraarterial injection of 6 mg of bupivacaine; that is, the total supplementary dose injected, despite a negative aspiration test. It is possible the injection was into the vasa vasorum of the carotid artery or that the tip of the needle was in the wall of the vessel on aspiration and moved during injection. Carotid body tumours are highly vascular and infiltration of the tumour could lead to retrograde flow into the carotid artery. Conversely, during carotid endarterectomy under local anaesthesia toxicity may be prevented because the low or absent flow in the relevant vessels prevents transmission of local anaesthetics directly to the brain by an artery.
